1Yarden Y.The EGFR family and its ligands in human cancer, signalling mechanisms and therapeutic opportunities[].European Journal of Cancer.2001
2Perez-Soler R,Chachoua A,Hammond L A,et al.Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer[].Journal of Clinical Oncology.2004
3Shepherd,FA.Erlotinib in previously treated non-small cell lung cancer[].The New England Journal of Medicine.2005
